Interpace Biosciences, Inc. (IDXG)
OTCMKTS: IDXG · Delayed Price · USD
1.470
0.00 (0.00%)
Apr 16, 2024, 3:36 PM EDT - Market closed
Interpace Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.21 | 31.84 | 41.31 | 32.4 | 24.08 | 21.9 | 15.9 | 13.09 | 9.43 | 119.94 | Upgrade
|
| Revenue Growth (YoY) | 26.31% | -22.94% | 27.52% | 34.55% | 9.97% | 37.74% | 21.49% | 38.73% | -92.14% | -20.49% | Upgrade
|
| Cost of Revenue | 17.17 | 13.61 | 23.37 | 21.67 | 15.89 | 10.2 | 7.36 | 6.64 | 6.91 | 101.39 | Upgrade
|
| Gross Profit | 23.04 | 18.23 | 17.95 | 10.73 | 8.19 | 11.7 | 8.54 | 6.44 | 2.52 | 18.54 | Upgrade
|
| Selling, General & Admin | 19.6 | 20.1 | 23.74 | 30.02 | 25.66 | 16.92 | 15.72 | 15.97 | 27.28 | 29.15 | Upgrade
|
| Research & Development | 0.64 | 0.7 | 1.88 | 2.8 | 2.81 | 2.12 | 1.46 | 1.65 | 2.29 | 0 | Upgrade
|
| Other Operating Expenses | -0.67 | 1.27 | 4.06 | 4.46 | 3.65 | 0.26 | -2.13 | 0.01 | -0.09 | -0.07 | Upgrade
|
| Operating Expenses | 20.23 | 22.07 | 29.68 | 37.28 | 32.12 | 22.3 | 20.43 | 21.38 | 33.38 | 29.93 | Upgrade
|
| Operating Income | 2.81 | -3.84 | -11.74 | -26.56 | -23.93 | -12.12 | -6.29 | -6.44 | -40.41 | -13.47 | Upgrade
|
| Interest Income | 0 | 1.01 | 1.04 | 0.55 | 0.44 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 1.01 | 1.01 | 0.92 | 0.55 | 0.44 | 0.33 | 0.43 | 2.14 | 3.71 | 0.6 | Upgrade
|
| Other Expense / Income | 0.98 | 2 | 3.8 | -0.41 | 2.73 | -0.28 | 5.89 | -0.09 | -19.62 | 6.74 | Upgrade
|
| Pretax Income | 1.13 | -5.84 | -15.41 | -26.15 | -26.67 | -12.19 | -13.13 | -8.57 | -44.21 | -14.14 | Upgrade
|
| Income Tax | 0.02 | 0.03 | -0.67 | 0.05 | -0.03 | 0.02 | -0.4 | -0.16 | -13.14 | -4.74 | Upgrade
|
| Net Income | 0.8 | -5.87 | -14.75 | -26.2 | -26.64 | -12.19 | -12.22 | -8.33 | -11.36 | -16.07 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 3 | 2 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 3 | 2 | 0 | 0 | 0 | Upgrade
|
| Shares Change | 2.97% | 2.49% | 2.63% | 7.55% | 33.03% | 78.61% | 768.17% | 17.31% | 3.89% | -89.88% | Upgrade
|
| EPS (Basic) | 0.19 | -1.38 | -3.57 | -6.50 | -7.11 | -4.33 | -7.75 | -45.88 | -73.36 | -107.87 | Upgrade
|
| EPS (Diluted) | 0.18 | -1.38 | -3.57 | -6.50 | -7.11 | -4.33 | -7.75 | -45.88 | -73.36 | -107.87 | Upgrade
|
| Free Cash Flow | 3.32 | -8.01 | -9.07 | -16.15 | -19.09 | -9.12 | -15.29 | -8.94 | -20.2 | -27.73 | Upgrade
|
| Free Cash Flow Per Share | 0.76 | -1.89 | -2.19 | -4.01 | -5.10 | -3.24 | -9.70 | -49.23 | -130.46 | -186.09 | Upgrade
|
| Gross Margin | 57.30% | 57.26% | 43.44% | 33.10% | 34.02% | 53.43% | 53.71% | 49.25% | 26.74% | 15.46% | Upgrade
|
| Operating Margin | 6.99% | -12.06% | -28.41% | -81.96% | -99.39% | -55.35% | -39.59% | -49.23% | -428.41% | -11.23% | Upgrade
|
| Profit Margin | 1.99% | -18.42% | -35.69% | -80.87% | -110.63% | -55.67% | -76.84% | -63.68% | -120.40% | -13.40% | Upgrade
|
| Free Cash Flow Margin | 8.25% | -25.17% | -21.96% | -49.86% | -79.27% | -41.66% | -96.19% | -68.32% | -214.11% | -23.12% | Upgrade
|
| Effective Tax Rate | 1.51% | - | - | - | - | - | - | - | - | - | Upgrade
|
| EBITDA | 3.84 | -3.78 | -8.18 | -21.63 | -20.09 | -7.08 | -10.77 | -11.16 | -25.93 | -9.06 | Upgrade
|
| EBITDA Margin | 9.54% | -11.88% | -19.80% | -66.75% | -83.41% | -32.34% | -67.75% | -85.25% | -274.86% | -7.55% | Upgrade
|
| Depreciation & Amortization | 1.03 | 2.56 | 5.37 | 5.5 | 4.19 | 3.46 | 3.69 | 4.48 | 5.03 | 2.39 | Upgrade
|
| EBIT | 2.81 | -6.34 | -13.56 | -27.13 | -24.27 | -10.55 | -14.46 | -15.64 | -30.96 | -11.45 | Upgrade
|
| EBIT Margin | 6.99% | -19.92% | -32.81% | -83.73% | -100.80% | -48.16% | -90.96% | -119.51% | -328.19% | -9.55% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.